Individual HDACs have been reported to be overexpressed in tumors, such as HDAC1 in prostate, gastric, colon, and breast cancer, and HDAC6 in breast cancer, suggesting that aberrant expression of HDACs is largely related to cancer. This evidence concerns the gene HDAC1 and breast carcinoma.